Evidence map›Paper›PMID 29090933›Full record

ArticleThe journal of physical chemistry. B2017

Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal Fluid.

Andrew J Clulow, Albin Parrow, Adrian Hawley, Jamal Khan, Anna C Pham, Per Larsson, Christel A S Bergström, Ben J Boyd

Open access · bronzeAbstract read
In one paragraph

Article in The journal of physical chemistry. B, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Small-volumeInternational journal of pharmaceutics: X · 2022
    Article
  6. Article
  7. Article
  8. Prediction of In Vitro Drug Dissolution into Fed-state Biorelevant Media: Contributions of Solubility Enhancement and Relatively Low Colloid Diffusivity.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Andrew J ClulowDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences , 381 Royal Parade, Parkville, VIC 3052, Australia.ORCID 0000-0003-2037-853X
Albin ParrowDepartment of Pharmacy, Uppsala Biomedical Centre, Uppsala University , P.O. Box 580, SE-751 23 Uppsala, Sweden.
Adrian HawleyAustralian Synchrotron, ANSTO , 800 Blackburn Road, Clayton, VIC 3168, Australia.
Jamal KhanDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences , 381 Royal Parade, Parkville, VIC 3052, Australia.
Anna C PhamDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences , 381 Royal Parade, Parkville, VIC 3052, Australia.
Per LarssonDepartment of Pharmacy, Uppsala Biomedical Centre, Uppsala University , P.O. Box 580, SE-751 23 Uppsala, Sweden.
Christel A S BergströmDepartment of Pharmacy, Uppsala Biomedical Centre, Uppsala University , P.O. Box 580, SE-751 23 Uppsala, Sweden.
Ben J BoydDrug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences , 381 Royal Parade, Parkville, VIC 3052, Australia.ORCID 0000-0001-5434-590X
Uppsala University · SEAustralian Nuclear Science and Technology Organisation · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absorption of hydrophobic drugs and nutrients from the intestine is principally determined by the amount that can be dissolved by the endogenous fluids present in the gut. Human intestinal fluids (HIFs) comprise a complex mixture of bile salts, phospholipids, steroids and glycerides that vary in composition in the fed and fasted state and between subjects. A number of simulated intestinal fluid (SIF) compositions have been developed to mimic fasted and fed state intestinal conditions and allow the in vitro determination of drug solubility as a proxy for the maximum dissolved concentration it is possible to reach. In particular these solvents are used during the development of lipophilic and poorly water-soluble drugs but questions remain around the differences that may arise from the source and methods of preparation of these fluids. In this work, a range of SIFs were studied using small-angle X-ray scattering (SAXS), cryogenic-transmission electron microscopy (cryo-TEM) and molecular dynamics (MD) simulations in order to analyze their structures. In-house prepared SIFs based on sodium taurodeoxycholate (NaTDC) and 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) formed oblate ellipsoidal micelles irrespective of lipid concentration and preparation conditions. In contrast, commercially available SIFs based on sodium taurocholate and lecithin formed prolate ellipsoidal micelles in the fed state and vesicles in the fasted state. These structural variations are the likely reason for the dramatic differences sometimes observed in the solubility enhancements for hydrophobic drugs, nutrients and digestion products when using different SIFs. However, the structural homogeneity of the NaTDC/DOPC micelles makes them ideal candidates for standardizing SIF formulations as the structures of the solubilizing nanoaggregates therein are not sensitive to the preparation method.

Indexed as

Molecular Dynamics SimulationBody FluidsHumansIntestinesMolecular ConformationNanostructuresPhosphatidylcholinesSolubilityTaurodeoxycholic Acid1,2-oleoylphosphatidylcholinePhosphatidylcholinesTaurodeoxycholic Acid

Identifiers

PMID29090933
PMCPMC6209315
OpenAlexW2765588569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.